Barbiturates

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Strong sedatives and anaesthetics. Derivatives of barbituric acid, malnonylurea. The different barbiturates differ especially in the duration of action. S.a. Phenobarbital.

Undesirable effectsThis section has been translated automatically.

Addiction, addiction, liver damage, drowsiness, ataxia, impaired judgment, poisoning, drug exanthema, bronchospasm, induction of systemic lupus erythematosus, aplastic anemia, leukopenia, pancytopenia, hemorrhages, barbiturate bladders.

InteractionsThis section has been translated automatically.

Enhancement of the effects of other centrally sedating substances. Enzyme induction in the liver with consecutively faster degradation of other drugs.

ContraindicationThis section has been translated automatically.

Porphyria, severe liver dysfunction, myocardial or renal damage, status asthmaticus, shock, acute intoxication with central attenuating drugs. S.a. Phenobarbital.

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer